Ali J. Satvat, Director at BridgeBio Pharma, holds 169.98K shares in BridgeBio Pharma (Ticker: BBIO), holds 30.00K shares in Coherus Biosciences (Ticker: CHRS), holds 24.58M shares in Eidos Therapeutics (Ticker: EIDX).
What is the percentage of profitable transactions made by Ali J. Satvat?
The percentage of profitable transactions made by Ali J. Satvat is 100%.
What is the average return per transaction made by Ali J. Satvat?
The average return per transaction made by Ali J. Satvat is 38.20%.
What stocks does Ali J. Satvat hold?
Ali J. Satvat holds: BBIO, CHRS, EIDX stocks.
What was Ali J. Satvat’s latest transaction?
Ali J. Satvat latest transaction was an Uninformative Buy of ―.
What was Ali J. Satvat's most profitable transaction?
Ali J. Satvat’s most profitable transaction was an Informative Buy of EIDX stock on May 29, 2019. The return on the trade was 57.20%.
What is Ali J. Satvat's role in BridgeBio Pharma?
Ali J. Satvat's role in BridgeBio Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.